CL Arteaga

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

CL Arteaga, Hurd Sd, TC Dugger et al. · PubMed · 1994 · 52 citations

Life Sciences, Cell Biology, Oncology +9

Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)

IA Mayer, Bojana Jovanović, V Abramson et al. · Cancer Research · 2013 · 14 citations

Medicine, Oncology, Pharmacology +17

Abstract GS6-05: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, VM Jansen et al. · Cancer Research · 2018 · 14 citations

Medicine, Oncology, Pharmacology +14

Abstract P2-14-04: A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer.

JA Means-Powell, S. E. Minton, IA Mayer et al. · Cancer Research · 2012 · 10 citations

Medicine, Oncology, Pharmacology +15